Effect of digital labels on electronic medical records for reducing the use of benzodiazepine receptor agonists

Kenji Shin, Daisuke Kobayashi, Takehiro Kawashiri, Keisuke Ikari, Hiroshi Mitsuyasu, Tomoya Murakami, Kazuki Tsutsumi, Yasunori Kanazawa, Hidetoshi Kamimura, Takao Shimazoe

Research output: Contribution to journalArticle

Abstract

Benzodiazepine receptor agonists (BZDs) should be appropriately used owing to the associated risks of delirium and falls. Since January 2018, the liaison team pharmacist at Iizuka Hospital has been applying digital labels with recommendations for the reduction of use and changes in the medication orders and prescriptions of BZDs on electronic medical records of patients in the surgical ward. This study aimed to verify the effectiveness of reducing the use of BZDs via the implementation of digital labels. Patients in the surgical ward were retrospectively assessed for changes in medication orders and prescription ratios of BZDs before and after the implementation of digital labels. The ratio of the number of digital labels implemented to the number of confirmations of medication orders and prescriptions of BZDs was 15.0% at the start of implementation; however, the ratio gradually and significantly decreased to 3.6%. The medication order ratio of BZDs was 52.2% before the implementation of digital labels; however, this ratio decreased to 2.7% and 5.6% immediately and 4 months after the implementation of digital labels, respectively. The present study showed that medication orders for BZDs were reduced after the implementation of digital labels and that the reduction effect was maintained for a certain period of time. Thus, the liaison team pharmacist-led approach can contribute to the proper use of BZDs.

Original languageEnglish
Pages (from-to)1449-1456
Number of pages8
JournalYakugaku Zasshi
Volume139
Issue number11
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Electronic Health Records
GABA-A Receptors
Prescriptions
Pharmacists
Delirium

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Effect of digital labels on electronic medical records for reducing the use of benzodiazepine receptor agonists. / Shin, Kenji; Kobayashi, Daisuke; Kawashiri, Takehiro; Ikari, Keisuke; Mitsuyasu, Hiroshi; Murakami, Tomoya; Tsutsumi, Kazuki; Kanazawa, Yasunori; Kamimura, Hidetoshi; Shimazoe, Takao.

In: Yakugaku Zasshi, Vol. 139, No. 11, 01.01.2019, p. 1449-1456.

Research output: Contribution to journalArticle

Shin, Kenji ; Kobayashi, Daisuke ; Kawashiri, Takehiro ; Ikari, Keisuke ; Mitsuyasu, Hiroshi ; Murakami, Tomoya ; Tsutsumi, Kazuki ; Kanazawa, Yasunori ; Kamimura, Hidetoshi ; Shimazoe, Takao. / Effect of digital labels on electronic medical records for reducing the use of benzodiazepine receptor agonists. In: Yakugaku Zasshi. 2019 ; Vol. 139, No. 11. pp. 1449-1456.
@article{c53addaa98d247b6b4ffc4f1d23f0db4,
title = "Effect of digital labels on electronic medical records for reducing the use of benzodiazepine receptor agonists",
abstract = "Benzodiazepine receptor agonists (BZDs) should be appropriately used owing to the associated risks of delirium and falls. Since January 2018, the liaison team pharmacist at Iizuka Hospital has been applying digital labels with recommendations for the reduction of use and changes in the medication orders and prescriptions of BZDs on electronic medical records of patients in the surgical ward. This study aimed to verify the effectiveness of reducing the use of BZDs via the implementation of digital labels. Patients in the surgical ward were retrospectively assessed for changes in medication orders and prescription ratios of BZDs before and after the implementation of digital labels. The ratio of the number of digital labels implemented to the number of confirmations of medication orders and prescriptions of BZDs was 15.0{\%} at the start of implementation; however, the ratio gradually and significantly decreased to 3.6{\%}. The medication order ratio of BZDs was 52.2{\%} before the implementation of digital labels; however, this ratio decreased to 2.7{\%} and 5.6{\%} immediately and 4 months after the implementation of digital labels, respectively. The present study showed that medication orders for BZDs were reduced after the implementation of digital labels and that the reduction effect was maintained for a certain period of time. Thus, the liaison team pharmacist-led approach can contribute to the proper use of BZDs.",
author = "Kenji Shin and Daisuke Kobayashi and Takehiro Kawashiri and Keisuke Ikari and Hiroshi Mitsuyasu and Tomoya Murakami and Kazuki Tsutsumi and Yasunori Kanazawa and Hidetoshi Kamimura and Takao Shimazoe",
year = "2019",
month = "1",
day = "1",
doi = "10.1248/yakushi.19-00087",
language = "English",
volume = "139",
pages = "1449--1456",
journal = "Yakugaku Zasshi",
issn = "0031-6903",
publisher = "公益社団法人 日本薬学会",
number = "11",

}

TY - JOUR

T1 - Effect of digital labels on electronic medical records for reducing the use of benzodiazepine receptor agonists

AU - Shin, Kenji

AU - Kobayashi, Daisuke

AU - Kawashiri, Takehiro

AU - Ikari, Keisuke

AU - Mitsuyasu, Hiroshi

AU - Murakami, Tomoya

AU - Tsutsumi, Kazuki

AU - Kanazawa, Yasunori

AU - Kamimura, Hidetoshi

AU - Shimazoe, Takao

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Benzodiazepine receptor agonists (BZDs) should be appropriately used owing to the associated risks of delirium and falls. Since January 2018, the liaison team pharmacist at Iizuka Hospital has been applying digital labels with recommendations for the reduction of use and changes in the medication orders and prescriptions of BZDs on electronic medical records of patients in the surgical ward. This study aimed to verify the effectiveness of reducing the use of BZDs via the implementation of digital labels. Patients in the surgical ward were retrospectively assessed for changes in medication orders and prescription ratios of BZDs before and after the implementation of digital labels. The ratio of the number of digital labels implemented to the number of confirmations of medication orders and prescriptions of BZDs was 15.0% at the start of implementation; however, the ratio gradually and significantly decreased to 3.6%. The medication order ratio of BZDs was 52.2% before the implementation of digital labels; however, this ratio decreased to 2.7% and 5.6% immediately and 4 months after the implementation of digital labels, respectively. The present study showed that medication orders for BZDs were reduced after the implementation of digital labels and that the reduction effect was maintained for a certain period of time. Thus, the liaison team pharmacist-led approach can contribute to the proper use of BZDs.

AB - Benzodiazepine receptor agonists (BZDs) should be appropriately used owing to the associated risks of delirium and falls. Since January 2018, the liaison team pharmacist at Iizuka Hospital has been applying digital labels with recommendations for the reduction of use and changes in the medication orders and prescriptions of BZDs on electronic medical records of patients in the surgical ward. This study aimed to verify the effectiveness of reducing the use of BZDs via the implementation of digital labels. Patients in the surgical ward were retrospectively assessed for changes in medication orders and prescription ratios of BZDs before and after the implementation of digital labels. The ratio of the number of digital labels implemented to the number of confirmations of medication orders and prescriptions of BZDs was 15.0% at the start of implementation; however, the ratio gradually and significantly decreased to 3.6%. The medication order ratio of BZDs was 52.2% before the implementation of digital labels; however, this ratio decreased to 2.7% and 5.6% immediately and 4 months after the implementation of digital labels, respectively. The present study showed that medication orders for BZDs were reduced after the implementation of digital labels and that the reduction effect was maintained for a certain period of time. Thus, the liaison team pharmacist-led approach can contribute to the proper use of BZDs.

UR - http://www.scopus.com/inward/record.url?scp=85074549549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074549549&partnerID=8YFLogxK

U2 - 10.1248/yakushi.19-00087

DO - 10.1248/yakushi.19-00087

M3 - Article

C2 - 31685741

AN - SCOPUS:85074549549

VL - 139

SP - 1449

EP - 1456

JO - Yakugaku Zasshi

JF - Yakugaku Zasshi

SN - 0031-6903

IS - 11

ER -